Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-24 @ 4:54 PM
Study NCT ID:
NCT04382950
Status:
UNKNOWN
Last Update Posted:
2021-06-09
First Post:
2020-05-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications
Sponsor:
Kafrelsheikh University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-10
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-08
First Submit QC Date:
None
Study First Post Date:
2020-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-05
Last Update Post Date:
2021-06-09
Last Update Post Date Type:
ACTUAL